Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 7Completed 7Withdrawn 1Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Diffuse Intrinsic Pontine Glioma 1

Interventions

Bevacizumab 4Specimen Handling 3Magnetic Resonance Spectroscopy 2Everolimus 2Biopsy 2trametinib 1relatlimab 1pembrolizumab 1lutetium Lu 177 dotatate 1fluoromisonidazole 1fludarabine phosphate 1antineoplaston AS 2-1 1antineoplaston A10 1aldesleukin 1X-Rays 1Transcranial Magnetic Stimulation 1TPI-287 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiosurgery 1Nivolumab 1Niacinamide 1Niacin 1Metformin 1Mental Status and Dementia Tests 1Magnetic Resonance Imaging 1Lomustine 1Lasers, Solid-State 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × antineoplaston AS 2-1 × CNS × Clear all
NCT02742883 2025-09-16

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

Burzynski Research Institute

Phase 2 Suspended
1 enrolled
CNS

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡